Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Clin Cancer Res. 2011 Jun 14;17(15):5016–5025. doi: 10.1158/1078-0432.CCR-11-0050

Figure 3. Effect of the FGF ligand trap, FP-1039, on growth of HNSCC cells.

Figure 3

The indicated HNSCC cell lines were submitted to anchorage-independent growth assays in the presence of the indicated concentrations of FP-1039 as described in the Materials and Methods. As shown in Figure 1, 584-A2, CCL30 and Detroit562, but not UMSCC19, express FGF2 mRNA and protein.

HHS Vulnerability Disclosure